Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 11,790
-40 (-0.34%)
At close: Apr 23, 2026
Penetrium Bioscience Market Cap
Penetrium Bioscience has a market cap or net worth of 657.16 billion as of April 24, 2026. Its market cap has increased by 792.63% in one year.
Market Cap
657.16B
Enterprise Value
660.41B
Revenue
9.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,790.00
Market Cap Chart
Since June 3, 2021, Penetrium Bioscience's market cap has increased from 215.74B to 657.16B, an increase of 204.60%. That is a compound annual growth rate of 25.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 657.16B | 404.20% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | 215.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 123.13B |
| HLB bioStep | 107.65B |
| P&K Skin Research Center | 74.80B |
| WOOJUNG BIO | 52.68B |
| C&R Research | 45.40B |
| DT&CRO CO. | 44.55B |
| SLS BIO | 26.89B |
| BioInfra | 20.77B |